CoreRx™ offers comprehensive drug product development services to the pharmaceutical and biotechnology industries. Supporting virtual, mid-size, and multinational companies, CoreRx offers customized formulation develop¬ment & clinical material manufacturing solutions. Our solutions maximize client investments, shorten development time, and reduce overall costs. From First-in-Man drug development, to full cGMP manufacturing support, CoreRx com¬bines 200+ years of pharmaceutical de¬velopment experience and expertise to produce safe, effective, and innovative drug products, on time, and on budget.
Company Background
CoreRx is a contract research and manufacturing organization located in Clearwater, FL. It was founded in 2006 by Todd Daviau, Jim Davis, Mark Licarde, and Brian McMillan. Over the course of 7 years, CoreRx has grown from 5 employees to over 50, and continues to advance in the industry.
Services & Capabilities
CoreRx offers complete contract drug development support and analysis, from formulation feasibility studies for proof-of-principal, to excipient compatibility evaluation, final product formulation optimization, cGMP clinical batch manufacturing, clinical packaging services, and complete analytical and stability testing. Additionally, CoreRx has the facilities and expertise to work on the most challenging drug formulation issues, including solubility concerns, unstable compounds, innovative delivery options, low dose formulations,controlled drugs, and high potency compounds.
Facilities
Currently occupying 35,000 square feet in Clearwater, FL, CoreRx has 13 cGMP manufacturing suites and 5 non-cGMP formulation suites. CoreRx has also acquired Myerlake II, which will feature 47,000 square feet of additional manufacturing
space dedicated to developing and manufactuing hormone products.